LACOSAMIDE

NDC 25021-791 · Sagent Pharmaceuticals

Generic nameLACOSAMIDE

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)LACOSAMIDE

Strength10 mg/mL

Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]

DEA scheduleCV

Marketing categoryANDA

Packages

25021-791-20 — 10 VIAL, GLASS in 1 CARTON (25021-791-20) / 20 mL in 1 VIAL, GLASS

FDA lists these products with the same active ingredient.

13811-207 — Lacosamide, 14445-129 — Lacosamide, 14445-130 — Lacosamide, 14445-131 — Lacosamide, 14445-132 — Lacosamide, 14445-406 — Lacosamide, 16714-548 — Lacosamide, 16714-549 — Lacosamide, 16714-550 — Lacosamide, 16714-552 — Lacosamide, 27808-243 — Lacosamide, 27808-244 — Lacosamide, 27808-245 — Lacosamide, 27808-246 — Lacosamide, 29300-364 — Lacosamide, 29300-365 — Lacosamide, 29300-366 — Lacosamide, 29300-367 — Lacosamide, 31722-203 — LACOSAMIDE, 31722-627 — Lacosamide, +141 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.